Attenuated poxvirus vectors as carriers in vaccines against human T cell leukemia-lymphoma virus type I.
Franchini
G
G
Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland 20892-4255, USA.
Benson
J
J
Gallo
R
R
Paoletti
E
E
Tartaglia
J
J
D000818:Animals; D005822:Genetic Vectors / Q000235:genetics / Q000276:immunology*; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000517:prevention & control*; D011212:Poxviridae / Q000235:genetics / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
C078788:ALVAC vaccine; C078787:NYVAC vaccine; D014613:Vaccines, Attenuated; D014765:Viral Vaccines